South Metropolitan Health Service
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
17
Active:0
Completed:9
Trial Phases
5 Phases
Phase 1:4
Phase 2:2
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (43.8%)Phase 1
4 (25.0%)Phase 2
2 (12.5%)Phase 4
2 (12.5%)Phase 3
1 (6.3%)Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- South Metropolitan Health Service
- Target Recruit Count
- 11
- Registration Number
- NCT05046665
- Locations
- 🇦🇺
Fiona Stanley Hospital, Murdoch, Western Australia, Australia
In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2015-11-10
- Lead Sponsor
- Fremantle Hospital and Health Service
- Target Recruit Count
- 15
- Registration Number
- NCT01726400
- Locations
- 🇦🇺
Fremantle Hospital, Fremantle, Western Australia, Australia
Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy
Phase 4
Completed
- Conditions
- Colonoscopy
- Interventions
- Drug: ColonlytelyDrug: Picolax/PicoprepDrug: Fleet
- First Posted Date
- 2008-09-11
- Last Posted Date
- 2009-08-25
- Lead Sponsor
- Fremantle Hospital and Health Service
- Target Recruit Count
- 676
- Registration Number
- NCT00750763
- Locations
- 🇦🇺
Department of Gastroenterology, Fremantle Hospital, Fremantle, Western Australia, Australia
News
No news found